CoChat

Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cells

Open access
Lisek, Kamil, Campaner, Elena, Ciani, Yari, Walerych, Dawid, Del Sal, Giannino · 2018 · Oncotarget
Cited by 118

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

// Kamil Lisek 1, 4 , Elena Campaner 1, 2 , Yari Ciani 1 , Dawid Walerych 1, 3 and Giannino Del Sal 1, 2 1 National Laboratory CIB, Area Science Park Padriciano, Trieste 34149, Italy 2 Department of Life Sciences, University of Trieste, Trieste 34127, Italy 3 Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw 02-106, Poland 4 Present address: Max-Delbrück-Centrum for Molecular Medicine, Berlin 13092, Germany Correspondence to: Giannino Del Sal, email: gdelsal@units.it Dawid Walerych, email: dwalerych@imdik.pan.pl Keywords: NRF2; mutant p53; cancer; oxidative stress Received: August 20, 2017 Accepted: March 09, 2018 Published: April 17, 2018 ABSTRACT NRF2 (NFE2L2) is one of the main regulators of the antioxidant response of the cell. Here we show that in cancer cells NRF2 targets are selectively upregulated or repressed through a mutant p53-dependent mechanism. Mechanistically, mutant p53 interacts with NRF2, increases its nuclear presence and resides with NRF2 on selected ARE containing gene promoters activating the transcription of a specific set of genes while leading to the transcriptional repression of others. We show that thioredoxin ( TXN) is a mutant p53-activated NRF2 target with pro-survival and pro-migratory functions in breast cancer cells under oxidative stress, while heme oxygenase 1 ( HMOX1) is a mutant p53-repressed target displaying opposite effects. A gene signature of NRF2 targets activated by mutant p53 shows a significant association with bad overall prognosis and with mutant p53 status in breast cancer patients. Concomitant inhibition of thioredoxin system with Auranofin and of mutant p53 with APR-246 synergizes in killing cancer cells expressing p53 gain-of-function mutants.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.24974

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

Metadata

Authors
Lisek, K., Campaner, E., Ciani, Y., Walerych, D., & Del Sal, G.
Venue
Oncotarget
Published
2018-04-17
Volume
9
Issue
29
Pages
20508-20523
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2799688671
Cited by
118
References
20
FWCI
4.16
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.